Clinical trial
Delapril and Manidipine for Nephroprotection in Diabetes (DEMAND)
NCT00157586 · Mario Negri Institute for Pharmacological Research, Other · Completed
Key facts
| NCT number | NCT00157586 |
|---|---|
| Title | Delapril and Manidipine for Nephroprotection in Diabetes (DEMAND) |
| Official title | A Multicenter, Randomized, Prospective, Double-blind Study to Evaluate the Nephroprotective Effect of Delapril Alone or Combined With Manidipine in Patients With Type 2 Diabetes |
| Lead sponsor | Mario Negri Institute for Pharmacological Research, Other |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Type 2 Diabetes |
| Intervention type | Drug |
| Interventions | Delapril, Delapril-Manidipine Fixed combination |
| Enrollment | 342 |
| Start date | Feb 1, 2002 |
| Completion | Jun 1, 2008 |
| First posted | Sep 12, 2005 |
| Last update posted | Apr 9, 2015 |
| Countries | Italy, Slovenia |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: